Please sign in to follow a disease.
Faster recovery after cervical stitch: Shorter-Acting spinal anesthetic tested
NCT ID NCT04394533
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial tests whether a shorter-acting spinal anesthetic (prilocaine) helps pregnant women recover feeling and movement faster after a cervical stitch procedure compared to the standard drug (bupivacaine). About 129 healthy pregnant women at risk of preterm loss will receive one of the two drugs via spinal injection. The goal is to see if prilocaine allows quicker return of leg strength and sensation, enabling earlier hospital discharge and less need for a urinary catheter.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Prilocaine (hyperbaric 2%) and Bupivacaine (hyperbaric 0.5%)
- What this could lead to
- If prilocaine works better, women could recover feeling and movement faster after a cervical stitch, leaving the hospital sooner and avoiding a urinary catheter.
- What could go wrong
- This is a small, single-center trial. The benefit may be modest, and prilocaine might not provide enough numbness for the procedure in some cases.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
129 people
The number who actually took part.
- Started
-
Aug 2021
- Finished
-
Aug 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Healthy (ASA score 2 or 3) pregnant women presenting for elective cervical cerclage under SAB. * Age \> 18 years Exclusion Criteria: * Inability to read or understand the patient information sheet (PIS) * Age \< 18 years * Unable or unwilling to consent to participation * non-elective procedure * serious co-morbidities (ASA score 4 or above) * any contraindication to SAB, e.g. local or generalised infection, active central nervous system disease, coagulation disorders or anti-coagulant medication * any history of allergic reaction to any of the medications in the protocol * concomitant use of class III anti-arrhythmics (sulfonamides, antimalarials, sodium nitroprussate, nitroglycerin, other local anaesthetics) * any contraindication to the use of bupivacaine or prilocaine as listed in the SmPCs.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cervical incompetence in pregnancy as antepartum condition are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Guy's and St Thomas' NHS Foundation Trust
London, SE1 7RT, United Kingdom